Compare ALRM & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALRM | CLDX |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 2015 | 1995 |
| Metric | ALRM | CLDX |
|---|---|---|
| Price | $44.59 | $33.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $56.67 | $46.60 |
| AVG Volume (30 Days) | 382.1K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.42 | N/A |
| EPS | ★ 2.46 | N/A |
| Revenue | ★ $1,011,187,000.00 | $12,743,000.00 |
| Revenue This Year | $7.00 | $111.39 |
| Revenue Next Year | $4.53 | $235.85 |
| P/E Ratio | $17.64 | ★ N/A |
| Revenue Growth | 7.59 | ★ 87.78 |
| 52 Week Low | $41.50 | $17.87 |
| 52 Week High | $59.98 | $35.83 |
| Indicator | ALRM | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 55.60 |
| Support Level | $42.14 | $28.30 |
| Resistance Level | $53.18 | $34.52 |
| Average True Range (ATR) | 1.35 | 1.20 |
| MACD | 0.17 | -0.10 |
| Stochastic Oscillator | 51.81 | 49.34 |
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.